The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responsesJosé M.A. Moreira(Active Biotech (Sweden)), Poul Sørensen(Active Biotech (Sweden))BMC CancerNovember 9, 200310.1186/1471-2407-3-30Cited by 143SaveCiteExport RISWatch citationsRelated PapersIdentification of BLCAP as a novel STAT3 interaction partner in bladder cancer|PLoS ONE|2017|14TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in <i>KRAS</i>-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer|Oncotarget|2016|9Salicylate-Elicited Activation of AMP-Activated Protein Kinase Directly Triggers Degradation of C-Myc in Colorectal Cancer Cells|Cells|2025|5